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Abstract
The rhizosphere isolate Pseudomonas putida BW11M1 produces a mixture of cyclic lipopeptide congeners, designated
xantholysins. Properties of the major compound xantholysin A, shared with several other Pseudomonas lipopeptides,
include antifungal activity and toxicity to Gram-positive bacteria, a supportive role in biofilm formation, and facilitation of
surface colonization through swarming. Atypical is the lipopeptide’s capacity to inhibit some Gram-negative bacteria,
including several xanthomonads. The lipotetradecadepsipeptides are assembled by XtlA, XtlB and XtlC, three co-linearly
operating non-ribosomal peptide synthetases (NRPSs) displaying similarity in modular architecture with the entolysin-
producing enzymes of the entomopathogenic Pseudomonas entomophila L48. A shifted serine-incorporating unit in the
eight-module enzyme XtlB elongating the central peptide moiety not only generates an amino acid sequence differing at
several equivalent positions from entolysin, but also directs xantholysin’s macrocyclization into an octacyclic structure,
distinct from the pentacyclic closure in entolysin. Relaxed fatty acid specificity during lipoinitiation by XtlA (acylation with 3-
hydroxydodec-5-enoate instead of 3-hydroxydecanoate) and for incorporation of the ultimate amino acid by XtlC (valine
instead of isoleucine) account for the production of the minor structural variants xantholysin C and B, respectively.
Remarkably, the genetic backbones of the xantholysin and entolysin NRPS systems also bear pronounced phylogenetic
similarity to those of the P. putida strains PCL1445 and RW10S2, albeit generating the seemingly structurally unrelated cyclic
lipopeptides putisolvin (undecapeptide containing a cyclotetrapeptide) and WLIP (nonapeptide containing a cyclohepta-
peptide), respectively. This similarity includes the linked genes encoding the cognate LuxR-family regulator and tripartite
export system components in addition to individual modules of the NRPS enzymes, and probably reflects a common
evolutionary origin. Phylogenetic scrutiny of the modules used for selective amino acid activation by these synthetases
indicates that bacteria such as pseudomonads recruit and reshuffle individual biosynthetic units and blocks thereof to
engineer reorganized or novel NRPS assembly lines for diversified synthesis of lipopeptides.
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Introduction
Certain genera of soil-dwelling and plant-associated bacteria,
such as Streptomycetes, Myxobacteria, Bacilli, Pseudomonads,
and Burkholderia, display a highly versatile secondary metabolism
and, hence, have proven valuable sources for structurally very
diverse metabolites with useful biological activities, including
antibiotics. Whereas Streptomyces and other actinomycetes are
major producers of clinical antibiotics, several antimicrobials from
other soil bacteria, such as Bacillus and Pseudomonas, contribute to
their capacity to suppress fungal plant diseases [1]. Such
biocontrol effect on phytopathogenic fungi by Pseudomonas strains
has been ascribed to in situ production of structurally diverse
molecules: 2,4-diacetylphloroglucinol, phenazines, pyrrolnitrin,
pyoluteorin, or lipopeptides [2]. Together with Bacillus, Pseudomonas
are prominent producers of lipopeptides with a range of different
biological activities: antagonism of microbial competitors, protec-
tion against predators, facilitation of surface motility, biofilm
formation, contribution to virulence of plant pathogens, triggering
of the defense response in plants [3].
Based on similarities in peptide length (ranging from 8 to 25
residues) and amino acid sequence, many of the lipopeptides
produced by Pseudomonas strains can be assigned to specific groups,
each named after a prototype compound: viscosin, amphisin,
syringomycin, syringopeptin, or tolaasin [4–6]. The largest group
with six subtypes is represented by viscosin and its analogs
massetolide, viscosinamide, pseudodesmin, pseudophomin, and
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WLIP (white line-inducing principle). In addition, several ‘orphan’
lipopeptides not belonging to one of the known families have been
described, namely putisolvin [7], orfamide [8], syringafactin [9],
and entolysin [10]. Quite often a particular Pseudomonas strains can
produce variants of a particular lipopeptide by attaching a
different fatty acid or by incorporation of a similar amino acid
at a certain position due to relaxed substrate specificity of the
biosynthetic enzymes. With the exception of syringafactins and its
analogs, cichofactins [11], all of these molecules are cyclic
lipopeptides, as they contain a macrocyclic lactone ring of variable
size formed between the carboxyterminal residue of the peptide
and an internal amino acid (serine or threonine).
The Pseudomonas biosynthetic genes for syringomycin, syringo-
peptin, syringafactin, arthrofactin, viscosin, orfamide, massetolide,
putisolvin, entolysin, WLIP, and cichofactin have been described
[5,8–18]. The encoded nonribosomal peptide synthetases (NRPSs)
are composed of multiple modules, each consisting of an
adenylation (A) domain responsible for amino acid selection and
activation, a thiolation (T) domain responsible for thioesterifica-
tion of the activated substrate, and a condensation (C) domain that
catalyzes peptide bond formation between two amino acids. The
starter condensation domain in the initiating enzyme (C1)
catalyzes acylation of the first amino acid, thereby linking the
lipid moiety to the oligopeptide [19,20]. Most known Pseudomonas
lipopeptide systems are of Type A, obeying the ‘‘co-linearity rule’’.
This indicates that the order and number of the NRPS modules
are co-linear to the amino acid sequence of the peptide product
[5,21]. Another characteristic is the frequent occurrence of a
tandem thioesterase (TE) domain in the terminating NRPS
domain required for release, usually with concomitant cyclization,
of the mature peptide product [6]. Multiple D-configured amino
acids have been identified in Pseudomonas lipopeptides with known
stereochemistry, but the corresponding synthetases lack standalone
epimerization (E) domains, as found in for instance Bacillus
lipopeptide NRPSs [6] or Pseudomonas pyoverdine synthetases [22].
This is attributed to the activity of dual C/E domains with
embedded L-to-D epimerization capacity acting on an amino acid
loaded on the T domain of a previous module [23].
Several Pseudomonas lipopeptides are harmful to fungi and
oomycetes but their antibacterial activities are mostly confined
to Gram-positive bacteria, while in general Gram-negative
bacteria seem to be better protected by their different cell
envelope architecture with a surface-exposed outer membrane
[24]. It was noted, however, that a number of Xanthomonas
species are susceptible to the cyclic lipopeptide WLIP, a
member of the viscosin group, produced by Pseudomonas putida
RW10S2 [17], Pseudomonas fluorescens LMG 5329 [18], and
Pseudomonas aurantiaca PB-St2 [25]. The c-proteobacterial genus
Xanthomonas represents a major group of plant-associated
bacteria, most of which cause plant diseases of economically
important mono- and dicot crops [26,27]. In a recent survey,
three of its species were ranked among the top ten pathogenic
bacteria of scientific and economic interest [28]. In plant
environments, competition for nutrients and space are likely to
occur between Xanthomonas and Pseudomonas as metagenomic
surveys have revealed that both genera of c-proteobacteria
constitute an important fraction of the microbial communities in
the rhizosphere and phyllosphere of diverse plants [29–32]. This
report describes the characterization of Xanthomonas-antagonistic
activity of Pseudomonas putida BW11M1, a strain isolated from
banana rhizosphere in Sri Lanka, revealing the involvement of a
new type of lipopeptide.
Results and Discussion
Xanthomonad-inhibitory Activity of P. putida BW11M1
Screening of a collection of Pseudomonas strains isolated from
tropical crop roots [33] revealed a broad xanthomonad-inhibitory
activity for the banana rhizosphere isolate P. putida BW11M1.
Using an agar diffusion assay, spotted BW11M1 cells produced a
growth inhibition halo with pathovars of different Xanthomonas
species as indicator overlay (Fig. 1). The growth inhibitory pattern
for some of these strains, such as X. translucens pv. cerealis LMG 679
and X. vasicola pv. musacearum LMG 785, consists of a clear halo
surrounded by a larger somewhat turbid halo, suggesting
sensitivity to more than one BW11M1 metabolite. As strain
BW11M1 is capable of killing pseudomonads by production of the
lectin-like toxin LlpA [34], it was verified whether this bacteriocin
might also be responsible for the observed growth inhibition of
xanthomonads, phylogenetic relatives of pseudomonads. Howev-
er, the latter antagonism was not affected in a BW11M1 llpA
mutant [35] and an Escherichia coli strain producing recombinant
LlpA [35] displayed no activity against Xanthomonas species,
demonstrating LlpA not to be involved (data not shown).
Furthermore, halo formation was not abolished by a non-specific
protease spotted close to BW11M1 producer cells, pointing to a
non-proteinaceous nature of the molecule(s) causing halo forma-
tion in the lawn of Xanthomonas cells (data not shown).
Identification of P. putida BW11M1 Mutants Lacking Anti-
Xanthomonas Activity
To identify mutants lacking anti-Xanthomonas activity, a P. putida
BW11M1 plasposon mutant library [35] was screened using X.
alfalfae subsp. alfalfae LMG 497 as indicator strain. Mutants lacking
anti-LMG 497 activity were isolated and subjected to plasposon
rescue [36] for subsequent sequencing of plasposon-flanking DNA
(Table S1). The majority of the mutants (23 out of 34) was
interrupted in genes showing similarity to NRPS genes, in
particular to those of Pseudomonas entomophila L48 encoding the
enzymes EtlA, EtlB and EtlC that synthesize the cyclic lipopeptide
entolysin [10]. In mutant CMPG2201, a BW11M1 gene was hit
that showed homology to etlR, the etlA-linked regulatory gene
required for entolysin production [10]. In addition to these
clustered insertions pointing to biosynthesis of a putative
(lipo)peptide, additional mutations in unlinked genes were
identified (Table S1). Although to be confirmed by phenotypic
complementation with the respective wild-type genes, these
mutations suggest that modified cell envelope characteristics
(lipopolysaccharide, exopolysaccharide, large surface protein)
may impair secretion of the secondary metabolite and that its
production may be triggered by stress factors (recB and clpB
mutants). The latter would be in line with the involvement of
DnaK and ClpP in the production of the lipopeptides putisolvin by
P. putida [37] and massetolide by P. fluorescens [15], respectively.
Further analysis focused on the NRPS-related genes of P. putida
BW11M1 apparently involved in biosynthesis of the substance
inhibitory to Xanthomonas, tentatively designated xantholysin. In
view of the anticipated large genomic DNA regions encoding
multi-modular megasynthases, a fosmid library of genomic
BW11M1 fragments was constructed. NRPS-specific PCR primers
were designed based on the plasposon-flanking DNA sequences for
the NRPS mutants listed in Table S1. Three amplicon-positive
fosmids, pCMPG6126, pCMPG6127 and pCMPG6128 with
estimated insert sizes of about 38 kb, 41 kb, and 40 kb respec-
tively, were selected. Sequence analysis of a shotgun library
constructed for the three pooled fosmids yielded six insert contigs
that enabled the localization of three NRPS genes, designated xtlA,
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xtlB and xtlC (acronym xtl referring to xanthomonad-lytic activity),
in two unlinked DNA regions (Fig. 2). All the plasposon insertions
in the NRPS mutants are confined to these three genes. In
addition, a putative regulatory gene interrupted in mutant
CMPG2201, designated xtlR, is located upstream and oriented
divergently of xtlA. Several Pseudomonas strains contain similarly
organized three-membered NRPS systems consisting of an
initiatory NRPS gene linked with a cognate LuxR-family gene,
but located remotely from the operon with the two other NRPS
genes. This genetic backbone structure was described for
biosynthesis of viscosin [14], massetolide [15], entolysin [10],
and WLIP [17,18]. This pronounced analogy suggested that a
non-ribosomal peptide is the likely product of the xtl-encoded
NRPSs.
Features of the P. putida BW11M1 NRPS System Required
for Xanthomonas Inhibition
In silico analysis revealed that the three NRPSs from strain
BW11M1, designated XtlA, XtlB and XtlC, comprise two, eight
and four modules, respectively, each composed of a condensation
(C), adenylation (A) and thiolation (T) domain (Fig. 2). A
thioesterase (TE) domain tandem is located at the carboxyterminal
end of XtlC. This architecture is quite similar to the P. entomophila
biosynthetic system EtlA-EtlB-EtlC assembling the cyclic lipote-
tradecapeptide entolysin [10]. The level of pairwise amino acid
sequence identities for XtlA/EtlA (75%), XtlB/EtlB (69%), and
XtlC/EtlC (72%) further suggests that a different lipopeptide is
synthesized by the sequential actions of the initiatory enzyme
XtlA, XtlB and the terminating enzyme XtlC.
From comparison of empirical data on the adenylating activities
of NRPS enzymes it has become possible to make enzyme primary
sequence-based predictions about the kind of substrate that is
loaded onto a specific module. The NPRSpredictor2 tool reports
the probable A-domain selectivity by comparative analysis of a 10-
amino acid diagnostic motif contained within the 34-amino acid
active site signature sequence ([38]; Table S2). An alternative
approach consists of a phylogenetic comparison of novel A
domains with those of functionally characterized NRPS systems,
which was carried out here for the known Pseudomonas lipopeptide
systems (Fig. 3). Application of both approaches suggested the
following sequence for the peptide moiety in xantholysin: Leu-
Glu/Asp-Gln-Val-Leu/Ile-Gln-Ser-Val-Leu/Ile-Gln-Leu-Leu-
Gln-Ile/Val/Leu. The Asp residue at the second position,
suggested by NRPSpredictor2 analysis (Table S2), deviates from
the phylogeny-based inference (Glu). The peptide sequence of
entolysin A differs from the xantholysin prediction in at least six
positions (underlined): Leu-Glu-Gln-Val-Leu-Gln-Val-Leu-Gln-
Ser-Val-Leu-Ser-Ile [10,39]).
Different types of C domains can be discerned by sequence-
based phylogenetic analysis [10,15,17,18,40,41]. Application of
this approach revealed that the XtlA-C1 domain clusters with
known starter domains in Pseudomonas lipopeptide synthetases (Fig.
S1), suggesting it to attach a fatty acid to the first amino acid. Only
two domains (XtlC-C12, XtlC-C13) are predicted to be conven-
tional C domains, the remaining eleven C domains being assigned
to the C/E type (Fig. 2). Such quantitative predominance of C/E
domains over regular C domains is a prominent feature of
Pseudomonas lipopeptide biosynthetic systems (Fig. S1), which
typically lack standalone epimerizing domains. In principal, a
C/E domain epimerizes the configuration of the amino acid that is
loaded onto the T domain of the previous module [23,42]. This
analysis suggests that most of the xantholysin residues would be in
the D configuration. However, a certain number of deviations
from such sequence-based prediction of Ca-epimerization have
been noted among Pseudomonas lipopeptides [8,15,17] and the
predicted stereochemistry requires experimental validation.
The termination module of XtlC harbors two thioesterase
domains (TE1/TE2 tandem) which is similar to most known
Pseudomonas lipopeptide biosynthesis systems, except for the
syringomycin group [6,43,44] (Fig. 2). Such thioesterase tandem
also occurs in LybB from the c-proteobacterium Lysobacter sp.
ATCC 53042 that catalyzes release and concomitant macro-
cyclization of the peptide lysobactin by its TE1 domain, while TE2
serves to deacylate misprimed T domains [42]. Analysis of
thioesterase domains from several Pseudomonas strains (Fig. S2)
shows that XtlC TE1 and TE2 domains indeed form separate
clusters and the pairwise similarities with the LybB domains
suggest a possible thioesterase task division between product
formation (TE1) and repair (TE2). The better sequence conser-
vation among TE2 domains compared to the TE1 sequences
(visualized by tighter TE2 clustering in Fig. S2) favors such general
editing function. Possibly, the TE1 catalytic activity for depsi-bond
formation co-evolved stronger for various peptide substrates in
which lactone rings of different sizes are formed between a
terminal residue and an internal serine or threonine. The
hydroxylated side-chain of the sole serine residue predicted for
xantholysin represents a likely candidate site for cyclization.
Xantholysin Production is Dependent on a Cognate
LuxR-family Regulator
The divergently transcribed gene upstream of xtlA, inactivated
in mutant CMPG2201 is predicted to encode a LuxR-family
protein (Fig. 2). Genes encoding such LuxR-type regulators have
been identified near the coding regions of most Pseudomonas
lipopeptide-synthesizing NRPS genes [45]. These proteins, specif-
ically controlling lipopeptide production, constitute a subfamily of
regulators that lack a N-acylhomoserine lactone-binding domain
and, consequently, are not involved in quorum sensing. The
putative regulator of P. putida BW11M1, tentatively designated
XtlR, clearly belongs to this sub-group of regulators (Fig. S3.A).
Figure 1. Growth inhibition of Xanthomonas species by P. putida BW11M1. Spotted BW11M1 cells (2 ml of 107 CFU/ml) were overlayed with
Xanthomonas indicator cells. (A) X. alfalfae subsp. alfalfae LMG 497; (B) X. axonopodis pv. manihotis LMG 784; (C) X. hortorum pv. hederae LMG 7411;
(D) X. sacchari LMG 471; (E) X. translucens pv. cerealis LMG 679; (F) X. translucens pv. graminis LMG 726; (G) X. translucens pv. hordei LMG 737; (H) X.
vasicola pv. holcicola LMG 736; (I) X. vasicola pv. musacearum LMG 785.
doi:10.1371/journal.pone.0062946.g001
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With its closest homologue, EtlR of P. entomophila required for
entolysin production [10], XtlR shares 75% amino acid identity.
To confirm the involvement of XtlR in regulation of xantholysin
production, mutant CMPG2201 was transformed with
pCMPG6204, carrying a cloned wild-type copy of xtlR. The
complemented mutant CMPG2201 showed anti-Xanthomonas
activity but somewhat lower than wild-type level (Fig. 4A). A
regulatory role for the equivalent genes was also reported for
production of syringafactin (syfR; [9]), putisolvin (psoR; [16]),
viscosin (viscAR; [45]), arthrofactin (arfF; [46]), and WLIP (wlpR;
[17]). A downstream-positioned LuxR-type regulator gene
(viscBCR; [45]) is also involved in viscosin production, but its
counterpart (pspto2833) is not required for production of
syringafactin [9]. No additional gene similar to viscBCR is present
downstream of the xtlBC operon (data not shown), which is also the
case for the wlpBC (WLIP) and etlBC (entolysin) operons [10,17].
Transporter Genes are Clustered with the Xantholysin
Biosynthetic Genes
The genes downstream of xtlC (xtlD-xtlE) and xtlR (xtlF)
potentially encode components of an export system for xantholysin
(Fig. 2). This genomic organization, with equivalent genes flanking
the initiating and terminating NRPS genes, is a recurrent theme
for several Pseudomonas lipopeptide gene clusters [10,15–18,47,48].
The XtlD-XtlE-XtlF system and its counterparts in other
lipopeptide-producing pseudomonads are similar to the ATP-
dependent tripartite macrolide efflux transporter MacA-MacB-
TolC system of E. coli [49], with the OprM-like outer membrane
proteins such as XtlF presumably operating as TolC equivalents in
these pseudomonads [50]. These putative BW11M1 transporter
components also showed the highest similarity to those of the
entolysin system (Fig. S3.B). Inactivation of the Mac-like
Pseudomonas genes downstream of the putisolvin [16], arthrofactin
[47], and syringopeptin [51] biosynthetic operons cause strongly
reduced but not completely abolished lipopeptide production,
indicating a major but non-exclusive role in export. Such
redundancy in lipopeptide export capacity may explain why no
xantholysin null mutants with insertions in these putative
transporter genes were identified. The involvement of an OprM
homologue in lipopeptide production by Pseudomonas has not yet
been experimentally verified.
The Antibacterial Activity of Xantholysin is not Restricted
to Xanthomonads
X. alfalfae subsp. alfalfae LMG 497 was used as an indicator
strain to identify BW11M1 mutants lacking xantholysin produc-
tion. To assess whether the observed inhibition of other
Xanthomonas strains also relies on this lipopeptide system, repre-
Figure 2. Xantholysin biosynthetic gene clusters of P. putida BW11M1. The organization of the genomic regions with the xantholysin
synthetases genes (xtlA, xtlB and xtlC), the associated regulatory gene (xtlR) and putative export genes (xtlD, xtlE and xtlF) is shown (GenBank
accession numbers: KC297505 (xtlFRA); KC297506 (xtlBCDE), together with the position of the sequenced fosmid-cloned genomic fragments.
Plasposon insertion sites generating mutants without antagonistic activity X. alfalfae subsp. alfalfae LMG 497 are indicated (solid lines). Mutants
selected for further phenotypic characterization are highlighted in blue font. For the encoded NRPS enzymes, the modular composition and domain
architecture is visualized. The predicted amino acid sequence is based on the substrate specificity of the 14 modules, as inferred by phylogenetic
analysis of Pseudomonas A-domain sequences (Fig. 3) and assuming consecutive co-linear biosynthesis by XtlA, XtlB and XtlC. The experimentally
determined structure of the main biosynthetic product, xantholysin A, is shown.
doi:10.1371/journal.pone.0062946.g002
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sentative anti-LMG 497 null mutants with a disrupted xtlA, xtlB,
xtlC or xtlR gene, were assayed for antagonism against other
Xanthomonas strains (Table S3). The lack of xantholysin production
coincided with disappearance of the single clear halo surrounding
the BW11M1 spot for sensitive strains such as X. axonopodis pv.
manihotis LMG 784 (Fig. 4A). For strains such as X. translucens pv.
cerealis LMG 679 with two concentric growth-inhibitory halo’s,
only the smaller clear halo disappeared. The latter was restored
Figure 3. Phylogeny-based substrate specificity prediction of xantholysin synthetases. Cladogram of maximum-likelihood tree inferred
from amino acid sequence alignment of adenylation (A) domains extracted from functionally characterized Pseudomonas NRPSs. Lipopeptide-specific
codes used for NRPS enzymes: Arf (arthrofactin, P. fluorescens MIS38); Etl (entolysin, P. entomophila L48); Mass (massetolide, P. fluorescens SS101); Ofa
(orfamide, P. fluorescens Pf-5); Pso (putisolvin, P. putida PCL1445); Syf (syringafactin, P. syringae DC3000); Syp (syringopeptin, P. syringae pv. syringae
B301D); Syr (syringomycin, P. syringae pv. syringae strain B301D); Visc (viscosin, P. fluorescens SBW25); Wip (WLIP, P. fluorescens LMG 5329); Wlp (WLIP,
P. putida RW10S2); Xtl (xantholysin, P. putida BW11M1; highlighted in larger bold font). For each domain the substrate specificity is indicated in
parentheses using the standard amino acid three-letter code (for xantholysin, as determined in this work). Non-protein amino acids are annotated as
follows: allo-threonine (aTHR); 2,3-dehydro-2-aminobutyric acid (DHB); 2,4-diaminobutyric acid (DAB); 3-hydroxyaspartate (OH-ASP); unidentified
residue (Leu or Ile) in putisolvin II (XLE). Clusters comprising xantholysin domains are highlighted in different colors. The tree was rooted with the
divergent SyrB1 domain.
doi:10.1371/journal.pone.0062946.g003
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Figure 4. Phenotypes of P. putida BW11M1 and xantholysin-deficient mutants. (A) Antagonistic activity against X. axonopodis pv. manihotis
LMG 784. (B) Antagonistic activity against X. translucens pv. cerealis LMG 679. (C) Formation of brown blotch on sliced Agaricus bisporus tissue. (D)
Hemolysis on horse blood TSB agar plate. (E) Swarming on 0.8% TSB agar plate. (F) Biofilm formation on pegs visualized by staining of adherent cells.
WT: BW11M1 wild type; xtlA, xtlB, xtlC, and xtlR: mutants CMPG2183, CMPG2187, CMPG2198, and CMPG2201, respectively; xltR+: mutant CMPG2201
with pCMPG6204 containing xtlR of P. putida BW11M1. The phenotypes shown for the selected xtlA, xtlB and xtlC mutants are representative for the
other xtl NRPS mutants (Table S1). The quantitative data for biofilm formation are shown in Fig. 5.
doi:10.1371/journal.pone.0062946.g004
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when assaying the complemented xtlR mutant, also linking this
phenotype to xantholysin production (Fig. 4B). With these
indicator strains, the larger turbid halo remained visible but the
zone of inhibition caused by the BW11M1 mutants was somewhat
reduced compared to the wild type (Table S3). The sensitivity of
xanthomonads to xantholysin from P. putida BW11M1 shows
qualitative and quantitative differences compared to WLIP-
mediated inhibition by P. putida RW10S2 [17]. For instance,
growth of the strain most sensitive to WLIP, X. citri pv. malvacearum
LMG 761, is only weakly affected by xantholysin production
(Table S3).
To further examine the antibacterial capacity of strain
BW11M1 and the role played by xantholysin production in this,
an expanded indicator panel composed of Gram-negative and
Gram-positive bacteria (Table S4) was tested against BW11M1
wild type and selected mutants. P. putida BW11M1 did not display
a broad inhibitory activity among other Gram-negative bacteria,
with six out of seventeen additional Gram-negative bacteria tested
being inhibited by strain BW11M1: the a-proteobacteria Azospir-
illum brasilense Sp7 and Sphingomonas wittichii RW1, the b-
proteobacteria Burkholderia vietnamiensis LMG 10927 and Variovorax
paradoxus LMG 1797, and the c-proteobacteria Aeromonas hydrophila
ATCC 7966 and Erwinia amylovora CFBP 1430 (Table S3). For the
Aeromonas, Burkholderia and Erwinia strains, xantholysin production
appears to be solely responsible for inhibition. The antagonistic
effect of strain BW11M1 exerted on pseudomonads, including
members of the P. syringae group, was not abolished in the
xantholysin mutants (data not shown), confirming that this is
bacteriocin-mediated [34].
Growth of most of the Gram-positive bacteria strains tested
(seven out of nine) was inhibited by strain BW11M1: the firmicutes
Bacillus megaterium ATCC 13632, Bacillus subtilis LMG 7135 and
Staphylococcus aureus ATCC 6358, and the actinomycetes Mycobac-
terium smegmatis DSM 43756, Rhodococcus erythropolis N11, Streptomyces
coelicolor A3(2) and Streptomyces lividans TK24. The residual
antagonistic activity towards these Gram-positive bacteria dis-
played by the xantholysin-deficient mutants again points to
production of (an)other growth-inhibitory factor(s) by P. putida
BW11M1 (Table S3). The antagonistic activity conferred by
xantholysin production based on mutant analysis was confirmed
for selected strains with purified xantholysin (purification described
below; Fig. S4). When testing this sample against rice pathogen X.
oryzae pv. oryzae, strains PXO99 and PXO112 proved sensitive,
whereas growth of strain PXO340 was not affected (data not
shown).
The inhibition of Gram-negative bacteria is a property not
typically associated with lipopeptides, whereas Gram-positive
bacteria are generally more susceptible [3]. In a comparative
study of the antagonistic activity of five Pseudomonas lipopeptides
(massetolide, syringomycin, orfamide, arthrofactin, and entolysin),
no significant inhibition of Gram-negative bacteria was observed
[24]. Conversely, among Gram-positive bacteria, an Arthrobacter
strain (actinomycete) was susceptible to all tested compounds,
except orfamide. Arthrofactin was also active against other
actinomycetes (Corynebacterium, Mycobacterium).
The Broad Antifungal Activity of P. putida BW11M1 is
mainly Dependent on Xantholysin Production
To further assess the antimicrobial potential of xantholysin, the
capacity of P. putida BW11M1 and its xantholysin-deficient
mutants to inhibit growth of several fungi was compared. Radial
mycelial outgrowth was delayed or arrested for most of the fungi
confronted with a colony of wild-type BW11M1 and this was
connected to xantholysin production (Fig. S5). In addition to
several ascomycetes, the basidiomycete Rhizoctonia solani was also
growth-inhibited. P. putida BW11M1 cells applied on the sliced
fruiting body of the basidiomycete Agaricus bisporus [52] resulted in
discoloration. This tissue damage was not visible for the
xantholysin-deficient mutants, indicating it to be dependent on
xantholysin production (Fig. 4C). Tissue discoloration was also
observed for the complemented xtlR mutant CMPG2201 carrying
pCMPG6204. No such blotch-like symptoms were observed
following application of a BW11M1 cell suspension onto intact
mushroom caps (data not shown).
Antifungal activity has been reported for several cyclic
lipopeptides belonging to different structural groups [3]. These
include tolaasin, a mycotoxin from the mushroom pathogen P.
tolaasii, and its analog sclerosin [53–55], amphisin [56], viscosina-
mide [57], thanamycin (syringomycin group; [58]), and syringo-
peptin [59]. Immobilization and lysis of oomycete zoospores is
caused by several viscosin-group members [3]. The in vitro
antifungal activity of entolysin has not been investigated, but
production of entolysin is not involved in the biocontrol activity of
P. entomophila L48 in a Pythium ultimum/cucumber setup [10].
Hemolytic Activity of P. putida BW11M1 is Mediated by
Xantholysin
Hemolytic activity has been reported for a number of
lipopeptides [10,17,48,54]. This phenotype can be readily
visualized by formation of a discoloured halo surrounding a
colony grown on blood agar. P. putida BW11M1 also shows
hemolytic activity, whereas mutants deficient in anti-Xanthomonas
activity are devoid of it (Fig. 4D). In the complemented xtlR
mutant CMPG2201 carrying pCMPG6204, hemolysis was
restored, in parallel with anti-Xanthomonas activity (Fig. 4A, 4B),
thus identifying xantholysin as the hemolytic factor produced by
strain BW11M1. Hemolysis by the structurally related lipopeptide
entolysin does not contribute to virulence of its entomopathogenic
producer [10].
Xantholysin is Required for Swarming and Contributes to
Biofilm Formation
For several Pseudomonas strains the involvement of lipopeptides
in swarming and biofilm formation has been reported
[3,17,18,48]. It was investigated whether these phenotypes are
equally associated with xantholysin production. The P. putida
BW11M1 mutants impaired in anti-Xanthomonas antagonism were
also deficient in swarming ability on soft agar (0.8%), compared to
the strong surface translocation capacity of the wild-type strain
(Fig. 4E). Swarming of the regulatory mutant (CMPG2201),
carrying a cloned xtlR copy (pCMPG6204), was comparable to the
wild-type behavior (Fig. 4E). This reveals a primary role for
xantholysin in swarming by P. putida BW11M1. Swarming
capacity is also affected in P. entomophila mutants lacking entolysin
production [10].
Compared to wild-type BW11M1 cells, the mutants deficient in
anti-Xanthomonas activity showed significantly reduced biofilm
formation at 30uC, but still retained almost half of the wild-type
capacity (Fig. 4F, Fig. 5). This indicates that xantholysin
contributes to BW11M1 biofilm formation under these experi-
mental conditions, acting together with other factors. Biofilm
formation by the complemented regulatory mutant was increased
to about 80% of wild-type biofilm formation (Fig. 5).
The lack of full complementation of the regulatory mutant to
wild-type level of biofilm formation, also observed to a certain
extent for antagonistic and hemolytic phenotypes, may be due to
some polar effect of the xtlR insertion on expression of the
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downstream oprM-like gene xtlF, encoding the presumed outer
membrane component of the tripartite transport system, possibly
diminishing xantholysin export. A complementation construct
carrying both xtlR and xtlF could not be obtained to test this
hypothesis.
Xantholysin A: a Novel Cyclic Lipotetradecadepsipeptide
LC-MS analysis of semi-purified extracts revealed the presence
of four lipopeptide compounds with molecular masses 1775.4 Da
(main compound, xantholysin A), 1761.2 Da (minor variant 1,
xantholysin B), 1802.0 Da (minor variant 2, xantholysin C) and
1775.2 Da (minor unidentified xantholysin variant 3, xantholysin
D) (Fig. S6, Fig. S7). Only xantholysin A could be successfully
isolated in sufficient quantity to allow adequate NMR analysis
(Fig. S8, Table S6).
The 2D 1H-1H TOCSY spectrum of xantholysin A in DMF-d7
(Fig. S9) allowed the identification of residues corresponding to
five Leu, one Ile, two Val, five Glx and one Ser by means of their
characteristic amino acid correlation patterns. The presence of a
3-hydroxydecanoic acid (HDA) moiety was determined from
combined analysis of the 1H-1H TOCSY and 1H-13C HSQC
spectra and comparison with the chemical shifts reported for
pseudodesmin A in dimethylformamide solution [17,60]. The
sequence (HDA-Leu1-Glx2-Glx3-Val4-Leu5-Glx6-Ser7-Val8-
Leu9-Glx10-Leu11-Leu12-Glx13-Ile14) was established by ob-
serving sequential Ha-HN cross-peaks in the 2D 1H-1H NOESY
spectrum (Fig. S10). The TOCSY and NOESY spectra also
revealed the presence of four individual pairs of mutually
correlated amide resonances originating from primary amide
functional groups. Correlations in the NOESY spectrum between
these resonances and the CH2
c and CH2
b resonances of the Glx
residues allowed specific assignment of each amide resonance pair
to a Glx residue, effectively establishing the identity of residues 3,
6, 10 and 13 to be Gln. The absence of any such correlations to
the CH2
c and CH2
b resonances of residue 2 and any further
primary amide group resonance pair in the spectrum established
the identity of residue 2 as Glu. The 1H-13C HMBC spectrum
allowed the assignment of several 13C carbonyl resonances from
the 2JCH coupling with the H
N resonances (Table S6). The
resulting peptide sequence (Leu-Glu-Gln-Val-Leu-Gln-Ser-Val-
Leu-Gln-Leu-Leu-Gln-Ile; Fig. 2) largely confirmed the phyloge-
ny-based prediction using an organism-specific subset of experi-
mentally confirmed A-domain sequences. A high-resolution mass
spectrum confirmed the chemical formula as C84H146N18O23
(exact mass: 1775.0764 Da; Fig. S11), thus indirectly providing
additional support for the number of Gln and Glu residues and the
length (C10) of the fatty acid chain.
At this point, the only feature of the proposed xantholysin A
structure which still remained to be confirmed was the depsi bond
between Ile14 and Ser7. The predicted molecular mass of the
above sequence when considering it as a linear lipopeptide
deviates 18 Da with the experimental value, in agreement with the
expected presence of the lactone bond. Based on previous
experience in assigning cyclic lipodepsipeptides [60], the only
direct demonstration of the existence of this bond would be by
detecting a 3JCH correlation between the C-terminal Ile14
carbonyl and the Ser7 CH2
b resonances in the HMBC spectrum.
While spectral overlap prevented convincing observation of such
correlation, indirect but clear evidence of the presence of the depsi
bond is found in the chemical shift of the Ser7 CH2
b protons,
which is significantly higher (4.38 ppm and 4.58 ppm) compared
to their random coil values (3.79 ppm and 3.95 ppm) [61]. A
similar downfield chemical shift for protons neighboring the depsi
bond is observable for other cyclic lipodepsipeptides as well [60]
and is explained by an anisotropic deshielding effect created by the
carbonyl double bond. This phenomenon can thus be seen as a
characteristic feature for this class of compounds, allowing quick
recognition of the presence and location of the depsi bond.
Importantly, the only other chemically feasible location of the
depsi bond – the alcohol group of the HDA moiety – can in this
way be excluded, since the HDA Hb resonance does not
experience such a strong downfield shift in comparison to other
cyclic lipodepsipeptides that were assigned by NMR [17,60].
The modest quantities obtained for the minor xantholysin
variants did not allow to record NMR data of sufficient quality for
a de novo analysis and full spectral assignment (Fig. S12, Fig. S13).
Nevertheless, direct comparison of the 1H-1H TOCSY and
1H-13C HSQC spectra for xantholysin B and C with the
corresponding spectra measured on xantholysin A allowed to
identify the nature of the variation. For both compounds, most of
the 1H and 13C chemical shifts were nearly identical to xantholysin
A, demonstrating their overall high similarity. In the case of
xantholysin B, the single observed difference is a substitution of the
Ile14 spin system for a Val spin system, explaining the 14 Da mass
difference (Fig. S14). The spectra indicated the lipid tail moiety of
xantholysin C to consist of 3-hydroxydodec-5-enoate (Fig. S13),
accounting for the 26 Da mass increase. High-resolution mass
spectra of both compounds confirmed the chemical formulae to be
C83H144N18O23 (exact mass: 1761.0574 Da) and C86H148N18O23
(exact mass: 1801.0900 Da) for xantholysin B and C, respectively
(Fig. S15, Fig. S16). Considerations of the 13C chemical shifts
within the lipid tail moiety of xantholysin C suggest the double
bond to be in the cis configuration (Fig. S17). This is reminiscent of
the promiscuous lipoinitiatory activity reported for Pseudomonas
corrugata producing similar amounts of corpeptin A (HDA) and
corpeptin B (3-hydroxydodec-5-enoic acid) [62]. In most lipopep-
tide-producing Pseudomonas, promiscuity is observed with respect to
chain length of the incorporated saturated 3-hydroxy fatty acids.
Relaxed amino acid substrate specificity, as observed here for the
terminal module in XtlC giving rise to minor amounts of
xantholysin B, is common among Pseudomonas NRPS systems
[5,8,9,43].
Xantholysin-like lipopeptides with antiviral activity were isolat-
ed from Pseudomonas sp. RtIB026. The main compound MA026
(PubChem CID 10285742) differs by two consecutive amino acids
(Leu10-Gln11 in MA026 versus Gln10-Leu11 in xantholysin A).
Congener R1MA026 (with Val9-Leu14) contains an additional
Figure 5. Biofilm formation by P. putida BW11M1 and
xantholysin-deficient mutants. Abbreviations as in Fig. 4. Error
bars indicate standard deviations. The analysis of variance (ANOVA) test
was used to evaluate significant differences (p,0.001; indicated with
different letters above the bars) between the wild type (set to 100%;
blue), mutants (red), and complemented regulatory mutant (green).
doi:10.1371/journal.pone.0062946.g005
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switch of two residues compared to xantholysin B (with Leu9-
Val14). Congener R2MA026 differs from MA026 by a 3-
hydroxydodec-5-enoyl instead of a 3-hydroxydecanoyl fatty acid
moiety (same as the difference between xantholysins A and C).
Given these striking similarities, it would be of interest to identify
the biosynthetic genes of strain RtIB026 (patent strain FERM BP-
7436) to compare the modular structure of its NRPSs with those of
the xantholysin system. The MA026 structure suggests a peculiar
A-domain switch between the last module of the second enzyme
and the first module of the third enzyme in RtIB026, compared to
XtlB and XtlC, respectively. Given the phylogenetic separation of
the Val- and Leu-selective A-domains of module 9 and 14 in
xantholysin (Fig. 3), the biosynthesis of an as yet unidentified Val9-
Leu14 congener by the xantholysin synthetases is unlikely. Since
for none of these RtIB026 structures a detailed NMR analysis is
available that would allow comparison to the xantholysins, it is at
this point still unclear whether indeed such striking biosynthetic
variation is occurring or whether the RtIB026 structures require
revision.
General Conclusions
Distinct Antibiotic Properties of Xantholysin
The identification of xantholysin adds to the growing list of
cyclic lipopeptides produced by pseudomonads. Like several other
Pseudomonas lipopeptides [3], xantholysin appears to promote
surface colonization of its producer, P. putida BW11M1, a strain
isolated from the rhizosphere of banana plants. However, unlike
most pseudomonad lipopeptides, antimicrobial activity is not
confined to fungi and Gram-positive bacteria, but also extends to
some Gram-negative strains, including several xanthomonads.
Members of this c-proteobacterial genus that are colonizing
similar plant niches as pseudomonads [29–32], are also susceptible
to WLIP, a member of the viscosin group [17], but Xanthomonas
strains exhibit differences in sensitivity to both lipopeptides.
During this study it became evident that, in addition to
xantholysin, strain BW11M1 produces one or more as yet
unidentified antimicrobial factor(s), also affecting a number of
xanthomonads. While xantholysin does not exert a growth-
inhibitory effect on fellow pseudomonads, P. putida BW11M1 also
produces a plant lectin-like bacteriocin to target other pseudomo-
nads, including members of the P. syringae group [35,63],
indicating that both ribosomally and non-ribosomally synthesized
antimicrobials are part of its armory deployed against competitors.
Antagonism among plant-associated c-proteobacterial relatives
has been described for some other types of pseudomonad
secondary metabolites: the modified amino acid 3-methylarginine
causing inhibition between P. syringae pathovars [64]; the salicylate-
containing P. putida antibiotic promysalin, targeting other pseudo-
monads [65]; oxyvinylglycines active against Erwinia amylovora
[66,67]. In view of the structural similarity of xantholysins to
certain pseudomonad lipopeptides with antiviral activity (viz.
MA026 and its congeners), future experiments should also address
the effects of xantholysins on enveloped viruses. Antiviral activity
has been reported for some other lipopeptides, such as viscosin and
surfactin [3].
Xantholysin and Entolysin Synthetases: Similar Enzymes
but Very Different Products
The genetic backbone of the xantholysin NRPS system bears
considerable similarity to the one for entolysin biosynthesis by the
P. putida relative P. entomophila L48 [10], both consisting of a
fourteen-unit assembly line with three enzymes operating in co-
linear mode (Fig. 6). Conservation of modular architecture is most
striking for the initiatory enzymes XtlA and EtlA, both composed
of two modules, and the subsequently acting enzymes, XtlB and
EtlB. Overall, the latter enzymes share eight probably equifunc-
tional modules but a single differently positioned serine-incorpo-
rating unit generates a different amino acid sequence stretch.
Furthermore, this apparent ‘‘serine switch’’ also shifts the site of
macrocyclization with three residues, such that xantholysin carries
an octacyclic moiety instead of the pentacyclic structure in
entolysin. Although the three NRPS enzymes from strains
BW11M1 and L48 share relatively high pairwise sequence
homology (70.5% amino acid identity for ,15,440 concatenated
residues), the architectural divergence engenders synthesis of quite
different molecules that can be assigned to separate groups within
the Pseudomonas lipopeptide classification, based on amino acid
sequence (length and similarity) and presence/type of macrocycle
[4–6].
Unexpected Similarities among Pseudomonas NRPS
Systems: the Advantage of being Modular
Phylogenetic comparison of the respective NRPS domains, the
linked LuxR-family regulator and the associated tripartite export
system consistently points to evolutionary relatedness of the
components of the xantholysin and entolysin systems with those
of P. putida strains generating lipopeptides that – at first glance –
show little structural similarity: putisolvin (twelve amino acids,
tetracyclic; [16]) and WLIP (nine amino acids, heptacyclic; [17]).
These four P. putida lipopeptides share a very similar A-domain
pair in the initiatory synthetases (EtlA, PsoA, WlpA, XtlA; Fig. 6).
The equivalent modules in the P. fluorescens starter enzymes for
incorporation of the same dipeptide (Leu-Glu) in viscosin-group
lipopeptides cluster separately from the P. putida ones [18]. From
Fig. 6 it is also apparent that xantholysin synthetase B shares a
core of five phylogenetically related contiguous modules with
putisolvin synthetase B (A-domains for Leu/Ile-Gln-Ser-Val-Leu/
Ile). Comparison of the A-module architecture of entolysin, WLIP
and putisolvin synthetases C points to a tripartite terminating
block composed of A-domains with common evolutionary origin,
but arranged in a different order in PsoC compared to EtlC and
WlpC.
Collectively, these observations suggest that these pseudomo-
nads probably have recruited and reshuffled gene modules to
engineer novel NRPS assembly lines for synthesis of new structural
lipopeptide variants. In combination with rapidly accumulating
genomic sequence data, high-throughput exploration of this part
of the ‘‘parvome’’ [68] becomes feasible with recently developed
strategies of mass spectral metabolic profiling of live microbial
colonies [44,69]. In addition to identification of new molecules and
associated biological activities, this will likely provide insight in the
extent of modular diversity among these biosynthetic enzymes,
and how this has been generated and further evolved in prominent
lipopeptide producers such as Pseudomonas and Bacillus.
Materials and Methods
Bacterial Strains, Plasmids and Culture Conditions
Bacterial strains and plasmids used are described in Table 1 and
Table S4. TSB growth medium (trypticase soy broth, 30 g/L; BD
Biosciences) was used for Pseudomonas and Xanthomonas strains at
30uC and for Klebsiella pneumoniae ATCC 13883 and Staphylococcus
aureus ATCC 6358 at 37uC. Aeromonas hydrophila ATCC 7966,
Agrobacterium tumefaciens A208, Azospirillum brasilense Sp7, Burkholderia
vietnamiensis LMG 10927, Mycobacterium smegmatis DSM 43756,
Rhodococcus erythropolis N11, Serratia entomophila DSM 12358,
Sphingomonas wittichii RW1, Variovorax paradoxus LMG 1797 and
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Yersinia enterocolitica LMG 7899 were grown at 30uC, and Bordetella
avium 197N, E. coli and Salmonella enteritidis ATCC 13076 at 37uC,
in LB (tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L).
Nutrient broth (8 g/L) was prepared for growing Bacillus megaterium
ATCC 13632 and Erwinia amylovora CFBP 1430 (at 30uC), and for
Citrobacter freundii ATCC 8090, Enterobacter aerogenes ATCC 13048,
Proteus vulgaris LMM 2011 and Shigella flexneri LMG 10472 (at
37uC). YEP (yeast extract 10 g/L, bacterial peptone 10 g/L) was
used for Burkholderia cepacia LMG 1222, TY (tryptone 5 g/L, yeast
extract 3 g/L, CaCl2 7 mM) for Bacillus subtilis LMG 7135 (all
grown at 30uC), and MRS (Difco lactobacilli MRS broth 55 g/L)
for Lactobacillus plantarum LMG-P21295 (cultured at 30uC) and
Lactobacillus rhamnosus GG (LMG 6400, at 37uC). Streptomyces
coelicolor A3(2) and Streptomyces lividans TK24 were cultivated in a
medium composed of 10 g casitone, 5 g yeast extract and 5 g
glucose per liter at 30uC. For solid media 15 g per liter agar was
added. Antibiotics were added at the following concentration
when required: kanamycin (50 mg/ml), ampicilin (100 mg/ml),
tetracycline (20 mg/ml).
Antibacterial Activity Assays by Agar Diffusion
P. putida BW11M1 was grown in 5 ml TSB for 8 h with shaking
(200 rpm). Two ml of this culture (OD600 ,1.8) was spotted onto a
TSB agar and incubated overnight at 30uC. After exposure to
chloroform vapor for 30 min to kill producer bacteria, the plates
were opened in a laminar flow chamber to evaporate residual
chloroform during another 30 min. Three ml of molten, semisolid
agar (0.5%) was inoculated with 100 ml of a bacterial indicator cell
culture (,108–109 CFU/ml) and poured onto the plates as an
overlay. Following day, plates (three replicates) were evaluated for
growth inhibition halos in a turbid lawn of indicator cells. Protease
sensitivity of the antimicrobial activity was verified by spotting
10 ml of proteinase K (20 mg/ml) near a chloroform-killed
producer colony prior to overlay.
Growth Inhibition of Fungi
An agar plug with fungal mycelium, grown for 1–2 weeks on
half-strength PDA (potato dextrose agar) medium was placed at
the center of an agar plate with appropriate medium at 20uC. PTA
medium (potato dextrose broth 12 g, TSB 3 g, agar 15 g per liter)
plates were used for most fungi. Alternaria porri was grown on 6CA-
TSB medium (Bambix 6 cereals 10 g, TSB 15 g, agar 15 g per
liter). 5 ml of overnight cell culture of P. putida BW11M1 and
selected xantholysin-deficient mutants were spotted at a distance of
,3 cm from the inoculum plug and incubated at 20uC for several
days up to two weeks, depending on the growth rate of the fungi,
before assessing the occurrence of mycelial growth inhibition
zones. Indicator fungi are listed in Table S5.
The effect of xantholysin production on Agaricus bisporus was
carried out as described by Bessette [52] with minor modifications.
Briefly, 20 ml of an overnight Pseudomonas culture (,108–
109 CFU/ml) was spotted onto horizontally sliced pilei of
mushroom basidiocarps (Agaricus bisporus). After absorption of the
liquid by the sterile surface, mushrooms were incubated overnight
at 30uC, sealed in a closed plastic box and saturated with water to
prevent drying out. Following day, mushrooms were scored for the
Figure 6. Modular architecture of the xantholysin synthetases and other Pseudomonas enzymes with similar A domains. The
respective starter NRPS genes are located distantly from the gene pairs encoding the middle and terminating NRPSs, except for the putisolvin operon
psoABC [16]. Synthesis of the peptide moiety by the consecutive action of the modules (with only A domains shown) proceeds in a co-linear fashion,
with incorporation of the respective amino acid at the positions corresponding to the numbered boxes. If a minor lipopeptide variant with a different
amino acid at a certain position has been identified, this residue is shown in parentheses with smaller font. Xle indicates that the residue’s identity
(either Leu or Ile) was not resolved in putisolvin II. The connected residues form a depsi bond. Similarity between the different systems is visualized
according to Rokni-Zadeh et al. [18]: two domains with a patristic distance,0.45 (summed branch lengths in a maximum-likelihood tree constructed
from aligned A-domain sequences; see Fig. 3) are represented in the same color.
doi:10.1371/journal.pone.0062946.g006
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presence of browning. Cultures of wild type and mutants were
tested in parallel (three independent biological repeats).
Isolation and Characterization of Mutants with Abolished
Anti-Xanthomonas Activity
A BW11M1 plasposon pTnMod-OKm’ mutant library [35] was
screened for mutants with abolished activity against indicator
strain X. alfalfae subsp. alfalfae LMG 497 by the agar diffusion
method. Each mutant from a 96-well microtiter plate was stamped
onto TSB agar square petri dishes (12612 cm) with a 96-prones
replicator. Mutants lacking anti-LMG 497 activity were selected
and confirmed twice. The plasposon-interrupted genes were
identified by the plasmid rescue method [36] and subsequent
sequencing of the flanking regions using pTnMod-OKm’-specific
primers PGPRB-0293 (59-TCTGGCTGGATGATGGGGCG-39)
and PGPRB-0294 (59-CGGTTCCTGGCCTTTTGCTGGC -
39).
Fosmid Library Construction and Screening
For construction of a P. putida BW11M1 genomic library in
fosmid pCC2FOS, the CopyControl HTP Fosmid Library
Production Kit protocol (Epicentre Biotechnologies) was applied.
Based on the flanking sequences identified in the plasposon
mutants, pairs of primers were designed to screen for fosmid clones
Table 1. Bacterial strains and plasmids.
Strain or plasmid Description and characteristicsa Source or Reference
Strains
E. coli TOP10F’ F9{lacIq, Tn10(TetR)} mcrA D(mrr-hsdRMS-mcrBC) W80lacZDM15 DlacX74 recA1
araD139 D(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
E. coli EPI300-T1R Host strain for pCC2FOS derivatives Epicentre Biotechnologies
E. coli DH5a supE44 DlacU169 (W80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 [70]
E. coli HB101 (pRK2013) Helper strain in triparental conjugation, Kmr [71]
P. putida BW11M1 Banana rhizosphere (Sri Lanka) [33]
P. putida CMPG2183 BW11M1 xtlA mutant This study
P. putida CMPG2187 BW11M1 xtlB mutant This study
P. putida CMPG2198 BW11M1 xtlC mutant This study
P. putida CMPG2201 BW11M1 xtlR mutant This study
X. alfalfae subsp. alfalfae LMG 497 Pathovar reference strain; Medicago sativa (Sudan) BCCMb
X. axonopodis pv. manihotis LMG 784 Pathovar reference strain; Manihot esculenta (Brazil) BCCM
X. campestris pv. campestris LMG 582 Brassica sp. (Belgium) BCCM
X. citri pv. malvacearum LMG 761 Pathovar reference strain; Gossypium sp. (Sudan) BCCM
X. hortorum pv. hederae LMG 7411 Hedera helix (USA) BCCM
X. sacchari LMG 471 Type strain; Saccharum officinarum (Guadeloupe) BCCM
X. sp. pv. zinniae LMG 8692 Pathovar reference strain; Zinnia elegans (Australia) BCCM
X. translucens LMG 12921 Anthurium andreanum (USA) BCCM
X. translucens pv. cerealis LMG 679 Pathovar reference strain; Bromus inermis (USA) BCCM
X. translucens pv. graminis LMG 726 Pathovar reference strain; Dactylis glomerata (Switzerland) BCCM
X. translucens pv. hordei LMG 737 Pathovar reference strain; Hordeum vulgare (India) BCCM
X. vasicola pv. holcicola LMG 736 Pathovar reference strain; Sorghum bicolor (New Zealand) BCCM
X. vasicola pv. musacearum LMG 785 Pathovar reference strain; Ensete ventricosum (Ethiopia) BCCM
X. vasicola pv. musacearum LMG 7431 Musa sp. (Ethiopia) BCCM
X. oryzae pv. oryzae PXO99 Race 6; Oryza sativa (The Philippines) IRRIc
X. oryzae pv. oryzae PXO112 Race 5; Oryza sativa (The Philippines) IRRI
X. oryzae pv. oryzae PXO340 Race 3; Oryza sativa (The Philippines) IRRI
Plasmids
pCC2FOS Copy control fosmid Epicentre Biotechnologies
pJB3Tc20 Broad-host-range cloning vector, Apr, Tcr [72]
pCMPG6126 Fosmid clone containing xtlA This study
pCMPG6127 Fosmid clone 12H4 containing xtlB and partial xtlC This study
pCMPG6128 Fosmid clone 19F2 containing xtlC and partial xtlB This study
pCMPG6204 pJB3Tc20 containing xtlR, Tcr This study
Other bacteria used as indicator strains are listed in Table S4.
aAntibiotic resistance phenotypes: Apr, ampicillin resistance, Kmr, kanamycin resistance; Tcr, tetracycline resistance.
bBCCM, Belgian Coordinated Collections of Microorganisms.
cIRRI, International Rice Research Institute.
doi:10.1371/journal.pone.0062946.t001
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containing the corresponding genomic DNA regions by colony
PCR. Selected clones were compared by end-sequencing using
pCC2FOS-specific primers PGPRB-1319 (59-GTACAACGA-
CACCTAGAC-39) and PGPRB-1320 (59-CAGGAAACAGCC-
TAGGAA-39). Finally, three fosmids with DNA fragments
covering the genomic regions of interest were sequenced at
Macrogen (Korea). The insert size of the fosmids was estimated by
separation of NotI-generated fragments using pulsed-field gel
electrophoresis. A high copy number of the fosmids was induced
by treating cells with the CopyControl Induction solution, prior to
extraction of the fosmids with the FosmidMAX DNA purification
kit (Epicentre Biotechnologies). The contigs with the regions
containing the functionally characterized genes were submitted to
GenBank (accession numbers KC297505 and KC297506).
Bioinformatic Analyses
Domains were identified using NRPS analysis tools [73,74].
The NRPSpredictor2 tool was used to predict amino acid
specificity of A domains [38]. Amino acid sequences were aligned
with MUSCLE for maximum-likelihood tree construction using
(PhyML with JTT matrix; [75]) as implemented in Geneious Pro
(version 5.6.3).
Complementation of xtlR Regulatory Mutant
Complementation of mutant CMPG2201 was performed as
previously described [17]. Briefly, the xtlR gene was amplified
using Platinum Pfx DNA polymerase (Invitrogen) with primers
PGPRB-8013 (59-TTGCTCTAGATCAGGTGCCGGCCATC-
CAGC-39) and PGPRB-8014 (59-CTCGGAATTCGGATCAAG-
GAAGACGACGAC-39) and cloned into the pJB3Tc20 vector
using the XbaI and EcoRI sites. The resulting construct
(pCMPG6204) was transferred to E. coli DH5a. Conjugative
transfer of pCMPG6204 to P. putida BW11M1 mutant
CMPG2201 was achieved by triparental conjugation using E. coli
HB101 bearing pRK2013 as helper strain. The phenotypes of a
selected transconjugant were compared to the regulatory mutant.
Swarming Motility, Biofilm Formation and Hemolytic
Activity
Swarming ability was studied by spotting 2 ml of 8 h-grown cells
on TSB medium solidified with 0.8% agar and evaluating surface
spreading after incubation at 30uC for 16 to 24 h (three repeats for
each sample). Biofilm formation was assayed according to Janssens
et al. [76] by using flat-bottom 96-well microtiter plates and
polystryrene pegs (Nunc, Sanbio b.v.). Cells grown for 8 hours
were adjusted to OD600 ,1.0 and then diluted 100-fold as initial
culture (200 ml per well, 8 wells per strain). After 2 days of
incubation at 30uC, biofilm formation was visualized by staining
pegs with 0.1% crystal violet. Stained biofilms were subsequently
extracted with 30% acetic acid and quantified by measuring
absorbance of the solution at 570 nm. Hemolytic activity was
assayed by spotting 2 ml of overnight-grown cells on TSB agar
with 5% horse blood (Oxoid) plates and hemolysis halos were
examined after incubating plates overnight at 30uC.
Lipopeptide Extraction and Purification
Overnight TSB-grown BW11M1 cell culture was used to
inoculate fresh TSB medium at a volume ratio of 1:100 and
incubated at 30uC for at least 2 days with shaking (200 rpm). After
removing cells through centrifugation (6370 g, 30 min, 4uC), the
supernatant was acidified by adding 9% HCl to lower the pH to
pH 2–3. The precipitate formed was isolated by centrifugation
(6370 g, 30 min, 4uC) and washed twice with acidified distilled
water (pH 3). Methanol was used to dissolve the pellet and the
solution was kept at 4uC till further purification. After evaporation
of solvent, the slurry was extracted with cold methyl tert-butyl ether
to precipitate the peptide fraction. This procedure was repeated
three times to obtain a crude peptide-rich mixture which was
further purified by preparative RP-HPLC. Samples were dissolved
in methanol (50 mg/ml) and eight injections of 1 ml were
performed on a Phenomenex column (Luna C18(2)
250621.2 mm, 5 mm particle size) operating at a flow rate of
17.5 ml/min. The ratio of the mobile phase solvents, 5 mM
ammonium acetate in water and acetonitrile, was changed in a
linear fashion from 50:50 to 10:90 over a time span of 15 minutes.
The major compound (xantholysin A) was collected based on UV
detection at l=214 nm. Two additional minor lipopeptides,
shown to be xantholysin variants B and C, were isolated by
analytical HPLC using an Agilent 1100 series instrument equipped
with a Phenomenex column (Luna C18(2), 25064.6 mm, 5 mm
particle size) and operating at a flow rate of 0.8 ml/min. The ratio
of mobile phase solvents, 5 mM ammonium acetate in water and
acetonitrile, was changed from 35:65 to 25:75 over a time span of
15 minutes. To identify bioactive fractions, samples from collected
fractions were spotted on a TSB agar plate and overlayed with
indicator cells after evaporation of the solvent (with non-polar
phase solvent as negative control).
Xantholysin Structure Elucidation
Initial mass spectra were acquired on a quadrupole orthogonal
acceleration time-of-flight mass spectrometer (Synapt G2 HDMS,
Waters, Milford, MA). Samples were infused at 3 ml/min and
spectra were obtained in positive ionization mode with a resolution
of 15000 FWHM and accuracy of 0.5 ppm RSD using leucine
enkephalin as lock mass. Additional LC-MS data were collected
on the extracted mixture prior to purification with an Agilent 1100
Series HPLC with an ESI detector type VL, equipped with a
Phenomenex column (Luna C18(2), 25064.60 mm, 5 mm particle
size). The flow rate was 1 ml/min. The mobile phase solvents,
5 mM ammonium acetate in water and acetonitrile, were linearly
changed from a 25:75 ratio to a 0:100 ratio over a time span of 15
minutes.
High-resolution mass spectra were recorded on an Agilent
6220A time-of-flight mass spectrometer, equipped with an Agilent
ESI/APCI multimode source. The ionization mode was set to
APCI (atmospheric pressure chemical ionization), while the mass
spectra were acquired in 4 GHz high-resolution mode with a mass
range set to 3200 Da. All NMR measurements on xantholysin A
were performed on a sample of 6.5 mg dissolved in 600 ml DMF-
d7 (Eurisotop). High quality HP-7 (New Era Ent. Inc) NMR tubes
were used. NMR experiments were performed on a Bruker
Avance III spectrometer operating at 500.13 MHz and
125.76 MHz for 1H and 13C, respectively, and equipped with a
5 mm 1H BBI-Z probe. Due to the low absolute quantities of
compound after purification, the xantholysin variants were
dissolved in 10 ml DMF-d7 for measurements using 1 mm
capillaries. In this case, NMR experiments were performed on a
Bruker Avance II spectrometer operating at 700.13 MHz and
176.04 MHz for 1H and 13C, respectively, and equipped with a
1 mm 1H, 13C, 15N TXI-Z probe. For both analysis of xantholysin
A and its variants, sample temperature was set to 55uC
throughout, as significant line broadening effects occurred at
lower temperatures. 2D spectra measured for structure elucidation
include a 1H-1H TOCSY with a 90 ms MLEV-17 spinlock, a
sensitivity-improved, multiplicity edited, 1H-13C gHSQC applying
adiabatic 180u pulses, a 1H -1H NOESY with a 300 ms mixing
time and a 1H-13C gHMBC experiment optimized for a carbon-
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proton coupling of 8 Hz. Standard pulse sequences as present in
the Bruker library were used throughout. Typically, 2048 data
points were sampled in the direct dimension for 256 data points in
the indirect one, with the spectral width respectively set to 12 ppm
along the 1H dimension and 110 ppm (gHSQC) or 220 ppm
(gHMBC) along the 13C dimension. For 2D processing, the spectra
were zero filled to obtain a 204862048 real data matrix. Before
Fourier transformation, all spectra were multiplied with a squared
cosine bell function in both dimensions except for the gHMBC
where a squared sine bell was applied.
Supporting Information
Figure S1 Cladogram representation of a maximum-
likelihood tree inferred from amino acid sequence
alignment of condensation domains extracted from
characterized Pseudomonas NRPSs. The lipopeptide-spe-
cific codes are specified in Fig. 3, with the xantholysin-related ones
in bold. Clusters are differentiated according to the type of C-
domain by color: conventional domains (green), dual epimeriza-
tion/condensation domains (blue), and N-acylating starter do-
mains (red). The tree was rooted with the divergent C1 domain of
SyrE (in black).
(PDF)
Figure S2 Maximum-likelihood tree of thioesterase
domains of characterized LP-producing Pseudomonas
NRPSs. The clusters with tandemly organized domains TE1 (red)
and TE2 (green) are shown in different colors. Lipopeptide-specific
codes as in Fig. 3, with the xantholysin-related ones in bold. The
tandem-TE domains of lysobactin synthetase LybB from Lysobacter
sp. ATCC 53042 and the mono-TE domain of syringomycin
synthetase SyrE from P. syringae pv. syringae B301D are included for
comparison. The internal residue involved in cyclization with the
carboxyterminal amino acid is specified for each TE1/TE domain
(NA=not applicable for the linear syringafactins; OH-Phe= b-
hydroxy phenylalanine). The scale bar represents 0.5 substitutions
per site.
(PDF)
Figure S3 Comparison of cognate regulators and asso-
ciated export systems in lipopeptide-synthesizing Pseu-
domonas. Maximum-likelihood trees inferred from amino acid
sequence alignments of (A) LuxR-family regulators encoded by
genes linked with the respective initiatory NRPS genes and (B) the
components of tripartite MacA/MacB/OprM-like export systems
(concatenated sequences; same phylogeny was obtained for the
three individual sequence sets (data not shown)). Lipopeptide-
specific codes as in Fig. 3, with the xantholysin-related ones in
bold. The regulatory gene encoding SyrF (panel A) is located
downstream of syrE. In panel B, the Syf and Arf systems are not
included (no sequences available for the corresponding OprM-like
protein). The scale bars represent 0.09 (panel A) and 0.04 (panel B)
substitutions per site. The xantholysin cluster (blue) and viscosin
cluster (green) are shown in different colors.
(PDF)
Figure S4 Growth inhibition of representative indicator
bacteria by purified xantholysin. 10 ml-samples of purified
xantholysin in methanol, containing 18 mg (A) or 9 mg (B) were
spotted on an agar plate and overlaid with indicator cells after
solvent evaporation. Methanol control spots did not cause growth
inhibition.
(PDF)
Figure S5 Antifungal activity of xantholysin. Growth
inhibition of fungi by P. putida BW11M1 (WT) and xantholysin-
deficient mutants (xtlA, xtlB, xtlC, xtlR; CMPG2183, CMPG2187,
CMPG2198, and CMPG2201, respectively). The application
pattern of bacterial cell suspensions spotted around a centrally
positioned plug with fungal mycelium is shown schematically in
(A). (B) Alternaria longipes CBS 620.83, (C) Ascochyta pisi
MUCL30164, (D) Botrytis cinerea MUCL30158, (E) Colletotrichum
gloeosporoides SR24, (F) Fusarium culmorum MUCL30162, (G)
Fusarium graminearum MUCL30161, (H) Fusarium oxysporum
MUCL909, (I) Fusarium oxysporum MUCL30160, (J) Fusarium
oxysporum f. sp. radices-lycopersi CBS 873.95, (K) Fusarium oxysporum
f. sp. vasinfectum CBS 410.90, (L) Gloeosporium musarum MUCL500,
(M) Gloesporium solani CBS 194.32, (N) Nectria haematococca
MUCL20259, (O) Pyrenophora tritici-repentis MUCL30217, (P)
Rhizoctonia solani CBS 211.84.
(PDF)
Figure S6 Chromatographic separation of xantholysin
congeners. LC-MS chromatogram of the extracted mixture
prior to purification using UV-detection at 214 nm.
(PDF)
Figure S7 Mass spectrometry of xantholysin congeners.
Mass spectra of xantholysin A and its variants obtained during
LC-MS analysis of the extracted mixture prior to purification.
Preliminary experiments with a high-resolution instrument showed
that the peaks represent ions with charge z = 2.
(PDF)
Figure S8 1D NMR analysis of xantholysin A. 1D 1H
spectrum of xantholysin A in DMF-d7 solution, 55uC, 500 MHz.
(PDF)
Figure S9 2D NMR analysis of xantholysin A. 2D 1H-1H
TOCSY spectrum of xantholysin A in DMF-d7 solution, 55uC,
500 MHz, revealing the characteristic amino acid spin system
patterns.
(PDF)
Figure S10 Nuclear Overhauser effect spectroscopy of
xantholysin A. Established NOE contacts in xantholysin A,
observed in a 2D 1H-1H NOESY spectrum with 300 ms mixing
time.
(PDF)
Figure S11 High resolution mass spectrum of xantholy-
sin A. (A) Full mass spectrum. (B) Zoom on the [M+H]+
molecular ion peaks. Expected exact mass of xantholysin A
(C84H146N18O23)+H+: 1776.0881 Da; observed exact mass of
xantholysin A+H+: 1776.0837 Da.
(PDF)
Figure S12 1D NMR analysis of xantholysin B. 1D 1H
spectrum of xantholysin variant 1, in DMF-d7 solution, 55uC,
700 MHz.
(PDF)
Figure S13 1D NMR analysis of xantholysin C. 1D 1H
spectrum of xantholysin variant 2, in DMF-d7 solution, 55uC,
700 MHz. The inset shows the signals arising from the alkene
protons of the 3-hydroxydodec-5-enoic acid moiety, on top of an
unidentified resonance from an impurity.
(PDF)
Figure S14 2D NMR analysis of xantholysin B. 2D 1H-1H
TOCSY spectrum of xantholysin variant 1, in DMF-d7 solution,
55uC, 700 MHz, revealing the characteristic amino acid spin
system patterns.
(PDF)
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Figure S15 High resolution mass spectrum of xantholy-
sin B. (A) Full mass spectrum. (B) Zoom on the [M+H]+ and
[M+Na]+ molecular ion peaks. Expected exact mass of xantholysin
B (C83H144N18O23)+H+: 1762.0724 Da; observed exact mass of
xantholysin B+H+: 1762.0647 Da.
(PDF)
Figure S16 High resolution mass spectrum of xantholy-
sin C. (A) Full mass spectrum. (B) Zoom on the [M+H]+ and
[M+Na]+ molecular ion peaks. Expected exact mass of xantholysin
C (C86H148N18O23)+H+: 1802.1037 Da; observed exact mass of
xantholysin C+H+: 1802.0973 Da.
(PDF)
Figure S17 NMR analysis of fatty acid moiety in
xantholysin C. 1H and 13C chemical shift comparison between
the lipid tail of xantholysin A and variant 2. (A) Experimental 1H
(red) and 13C (blue) chemical shifts of the xantholysin 3-
hydroxydecanoic acid moiety, compared to predicted 13C
chemical shifts (green). (B) Experimental 1H (red) and 13C (blue)
chemical shifts of the xantholysin variant 2 3-hydroxydodec-5-
enoic acid moiety, compared to predicted 13C chemical shifts
(green) assuming a cis-configuration. (C) Predicted 13C (green)
chemical shifts of the xantholysin variant 2 3-hydroxydodec-5-
enoic acid moiety assuming a trans-configuration. 13C chemical
shift predictions were calculated using ChemNMR Pro 12.0 as
implemented in the ChemDraw Ultra 12.0 software (PerkinElmer,
Inc.). In the case of cis-3-hydroxydodec-5-enoic acid, the predicted
13C chemical shifts indicate a decrease in both the c and f 13C
chemical shifts compared to the HDA moiety
(36.8 ppmR33.1 ppm and 29.3 ppmR27.7 ppm respectively).
In the case of the trans-3-hydroxydodec-5-enoic acid, an increase
in these same chemical shifts is predicted (36.8 ppmR39.1 ppm
and 29.3 ppmR33.7 ppm respectively). In the cis configuration,
the van der Waals radii of the hydrogens of the two carbons
flanking the double bond are overlapping due to their spatial
proximity, as opposed to the trans configuration. This steric
compression causes an additional shielding and thus upfield shift of
the associated carbons, which is not present in the case of the trans
configuration (for reference, see Breitmaier E., Voelter E. (1987)
Carbon-13 NMR Spectroscopy: High-Resolution Methods and
Applications in Organic Chemistry and Biochemistry, 3rd edition.
Weinheim: VCH Verlagsgesellschaft mbH. 515 p.). The experi-
mental values of the 3-hydroxydodec-5-enoic acid moiety
compared to those of the HDA moiety (37.91 ppmR35.53 ppm
and 29.60 ppmR27.28 ppm for the c and f 13C nuclei
respectively) show that the 13C chemical shifts correspond
significantly better to the case of the cis-configuration, indeed
showing a decrease. Therefore, this provides a significant
indication for the lipid tail in xantholysin variant 2 to be in the
cis-configuration.
(PDF)
Table S1 Characterization of antibacterial activity of P.
putida BW11M1. Homology of genes disrupted in BW11M1
plasposon mutants lacking antibacterial activity using X. alfalfae
subsp. alfalfae LMG 497 as indicator strain.
(PDF)
Table S2 In silico analysis of adenylation domains in
xantholysin synthetases. Predicted substrate specificity of the
A domains in the xantholysin NRPSs.
(PDF)
Table S3 Antagonistic activity spectrum of P. putida
BW11M1 wild type (WT) and xantholysin-deficient
mutants. The indicators shown are listed in Table 1 and Table
S4. All other bacteria listed in Table S4 are not inhibited by strain
BW11M1. Antagonism was semi-quantified by measuring the halo
radii (in mm; average of three repeats; ND, no halo detected).
Values in parentheses denote formation of a turbid halo. For some
wild-type Xanthomonas strains a larger turbid halo was observed
around a smaller clear halo. Additional italicized values in
parentheses refer to the presence of a ‘secondary’ turbid growth
inhibition halo.
(PDF)
Table S4 Analysis of bacterial susceptibility to P. putida
BW11M1. List of non-Xanthomonas bacteria used as indicators.
(PDF)
Table S5 Antifungal activity of P. putida BW11M1 and
xantholysin-deficient mutants. The effect on mycelial growth
near a bacterial colony is indicated: (+) inhibition by wild type; (Q)
or (2), reduced or no inhibition by xtl mutants compared to WT
(as observed on PTA medium). For a particular indicator, the
same phenotype was observed for the xtlA, xtlB, xtlC and xtlR
mutants (CMPG2183, CMPG2187, CMPG2198, and
CMPG2201, respectively), collectively designated xtl mutants.
The inhibitory patterns for selected fungal strains are shown in Fig.
S5.
(PDF)
Table S6 NMR analysis of xantholysin A. 1H and 13C
NMR assignment of xantholysin A in DMF-d7 solution, 55uC.
(PDF)
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